Photo from academic.microsoft.com
HIGHLIGHTS • baricitinib and tofacitinib are effective in patients with Rhupus • JAK inhibitors are an alternative option in patients with refractory SLE • JAK inhibitors have a steroid-sparing effect… Click to show full abstract
HIGHLIGHTS • baricitinib and tofacitinib are effective in patients with Rhupus • JAK inhibitors are an alternative option in patients with refractory SLE • JAK inhibitors have a steroid-sparing effect in patients with Rhupus
Keywords:
inhibitors treating;
patients rhupus;
kinases inhibitors;
treating patients;
janus kinases
Journal Title: Joint bone spine
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Joint bone spine
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!